Cardiovascular research hub

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

This study is testing a new medicine called CTX310 for people in the UK with high cholesterol and fats in their blood that haven't improved with usual treatments. It will check if the medicine is safe and how well people tolerate different doses. It's an early-stage study.